Inventor
SHULTZ MICHAEL DAVID
US15 patents
⚠️ This page may combine multiple inventors who share the name “SHULTZ MICHAEL DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
10 patentsUS10287266B2May 14, 2019
Compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG8 citations82
US9688672B2Jun 27, 2017
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
NOVARTIS AG2 citations71
US11548865B2Jan 10, 2023
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG2 citations70
US11485742B2Nov 1, 2022
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG2 citations70
US12122761B2Oct 22, 2024
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG0 citations59
US11820778B2Nov 21, 2023
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG0 citations59
US10112931B2Oct 30, 2018
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
NOVARTIS AG0 citations51
US9822092B2Nov 21, 2017
ArylSulfonamide-based matrix metalloprotease inhibitors
NOVARTIS AG0 citations51
US8975439B2Mar 10, 2015
Arylsulfonamide based matrix metalloprotease inhibitors
NOVARTIS AG0 citations51
USRE46942EJul 10, 2018
4-piperidinyl compounds for use as tankyrase inhibitors
NOVARTIS AG0 citations50